Advance articles

Research Article 28 April 2025

Stroke risk stratifications according to CHA₂DS₂-VASc vs. CHA₂DS₂-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry

Steven Ho Man Lam and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf031, https://doi.org/10.1093/ehjcvp/pvaf031
- View article
- Supplementary data
News 26 April 2025

Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice

Felice Gragnano and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf032, https://doi.org/10.1093/ehjcvp/pvaf032
- View article
Research Article 26 April 2025

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis

Xuan Ci Mee and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf026, https://doi.org/10.1093/ehjcvp/pvaf026
- View article
- Supplementary data
Research Article 25 April 2025

Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis

Giuseppina Novo and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf028, https://doi.org/10.1093/ehjcvp/pvaf028
- View article
- Supplementary data
Research Article 24 April 2025

Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants

Shun Sasaki and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf030, https://doi.org/10.1093/ehjcvp/pvaf030
- View article
- Supplementary data
Research Article 24 April 2025

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis

Damien Legallois and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf027, https://doi.org/10.1093/ehjcvp/pvaf027
- View article
- Supplementary data
Review Article 18 April 2025

Early initiation of SGLT2 inhibitors after acute myocardial infarction

Andeas Hammer and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf020, https://doi.org/10.1093/ehjcvp/pvaf020
- View article
News 12 April 2025

Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies

Filippo Luca Gurgoglione and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf025, https://doi.org/10.1093/ehjcvp/pvaf025
- View article
Correction 8 April 2025

Correction to: Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf013, https://doi.org/10.1093/ehjcvp/pvaf013
- View article
Review Article 2 April 2025

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies

Andrea Rubboli and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf021, https://doi.org/10.1093/ehjcvp/pvaf021
- View article
Research Article 1 April 2025

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Anthony Elhadad and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf019, https://doi.org/10.1093/ehjcvp/pvaf019
- View article
- Supplementary data
News 29 March 2025

Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives

Mattia Galli and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf022, https://doi.org/10.1093/ehjcvp/pvaf022
- View article
Review Article 26 March 2025

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)

Dan Atar and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf006, https://doi.org/10.1093/ehjcvp/pvaf006
- View article
Research Article 20 March 2025

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results

So-Ryoung Lee and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf018, https://doi.org/10.1093/ehjcvp/pvaf018
- View article
- Supplementary data
Editorial 13 March 2025

CLEAR results, cloudy impact: colchicine's neutral role in ST-segment elevation myocardial infarction

Claudio Laudani and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf011, https://doi.org/10.1093/ehjcvp/pvaf011
- View article
Editorial 10 March 2025

AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

Felice Gragnano and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf008, https://doi.org/10.1093/ehjcvp/pvaf008
- View article
Review Article 8 March 2025

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024

Juan Tamargo and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf012, https://doi.org/10.1093/ehjcvp/pvaf012
- View article
- Supplementary data
Review Article 6 March 2025

Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment

Klaus G Parhofer and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf007, https://doi.org/10.1093/ehjcvp/pvaf007
- View article
Review Article 25 February 2025

Trial-level surrogacy of non-high-density and low-density lipoprotein cholesterol reduction on the clinical efficacy of statins

Léa Liaigre and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf016, https://doi.org/10.1093/ehjcvp/pvaf016
- View article
- Supplementary data
Research Article 17 February 2025

Prognostic benefit of glucagon-like peptide-1 receptor agonists addition to sodium-glucose cotransporter 2 inhibitors in patients with atherosclerotic cardiovascular disease and heart failure: a cohort study

Sih-Yao Chen and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf014, https://doi.org/10.1093/ehjcvp/pvaf014
- View article
- Supplementary data
Research Article 17 February 2025

Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study

Nhu Ngoc Le and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf015, https://doi.org/10.1093/ehjcvp/pvaf015
- View article
- Supplementary data
Letter 7 February 2025

Inotropes and mortality in patients with cardiogenic shock: more questions than answers

Achim Lother and Dawid L Staudacher

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf010, https://doi.org/10.1093/ehjcvp/pvaf010
- View article
Research Article 4 February 2025

Valve thrombosis and antithrombotic therapy after bioprosthetic mitral valve replacement: a systematic review and meta-analysis

Mark J Zorman and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvaf005, https://doi.org/10.1093/ehjcvp/pvaf005
- View article
- Supplementary data
Research Article 3 January 2025

A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study

Claudio Laudani and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvae100, https://doi.org/10.1093/ehjcvp/pvae100
- View article
- Supplementary data
Research Article 24 December 2024

Risk of bleeding with the concurrent use of amiodarone and DOACs: a systematic review and meta-analysis

Faith Michael and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvae097, https://doi.org/10.1093/ehjcvp/pvae097
- View article
- Supplementary data
Research Article 13 November 2024

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome

Wout Willem Antoon van den Broek and others

European Heart Journal - Cardiovascular Pharmacotherapy, pvae087, https://doi.org/10.1093/ehjcvp/pvae087
- View article
- Supplementary data

Advance articles

Stroke risk stratifications according to CHA₂DS₂-VASc vs. CHA₂DS₂-VA in patients with Atrial Fibrillation: insights from the GLORIA-AF registry

Long-term Antiplatelet Monotherapy After PCI: Searching for the Smart Choice

SGLT2 Inhibitors and Cardiovascular Outcomes in Patients with Acute Myocardial Infarction: A Retrospective Cohort Analysis

Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis

Albumin Level and Risk of Major Bleeding in Patients with Atrial fibrillation on Direct Oral Anticoagulants

Identification of Anticancer Drugs Associated to Cancer Therapy-Related Cardiac Dysfunction: A VigiBase® Disproportionality Analysis

Early initiation of SGLT2 inhibitors after acute myocardial infarction

Can SGLT-2 Inhibitors Stabilize Coronary Atherosclerotic Plaques? Evidence from Imaging Studies

Correction to: Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials

Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies

Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock

Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives

Apixaban outcomes in atrial fibrillation patients with a single-dose reduction criterion: ASPIRE 1-year results

CLEAR results, cloudy impact: colchicine's neutral role in ST-segment elevation myocardial infarction

AZALEA–TIMI 71 trial: less bleeding with abelacimab compared to rivaroxaban in atrial fibrillation, but stroke prevention is uncertain

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024

Expert opinion on the integration of combination therapy into the treatment algorithm for the management of dyslipidaemia: the integration of ezetimibe and bempedoic acid may enhance goal attainment

Trial-level surrogacy of non-high-density and low-density lipoprotein cholesterol reduction on the clinical efficacy of statins

Prognostic benefit of glucagon-like peptide-1 receptor agonists addition to sodium-glucose cotransporter 2 inhibitors in patients with atherosclerotic cardiovascular disease and heart failure: a cohort study

Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study

Inotropes and mortality in patients with cardiogenic shock: more questions than answers

Valve thrombosis and antithrombotic therapy after bioprosthetic mitral valve replacement: a systematic review and meta-analysis

A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study

Risk of bleeding with the concurrent use of amiodarone and DOACs: a systematic review and meta-analysis

Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome

Email alerts

RSS Feeds

Latest

Most Read

Most Cited

Advance articles

Email alerts

RSS Feeds

This Feature Is Available To Subscribers Only